Related Experiment Video
Updated: May 15, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Standardization and Prediction to Control Confounding: Estimating Risk Differences and Ratios for Clinical
A Russell Localio1, James A Henegan2, Stephanie Chang3
1Division of Biostatistics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (A.R.L.).
Estimating health risks like death from smoking requires clear metrics. Standardization in statistical modeling provides transparent risk estimates, overcoming limitations of odds ratios often misinterpreted in biomedical research.
Area of Science:
- Biostatistics
- Epidemiology
- Public Health
Background:
- Logistic regression is common for biomedical risk questions.
- Odds ratios are frequently misunderstood, hindering clear interpretation.
- Standard statistical models have limitations for causal inference.
Purpose of the Study:
- To review standardization concepts and link them to regression modeling for causal inference.
- To compare weighting and matching approaches with regression-based standardization.
- To demonstrate clinically meaningful risk estimation using standardization.
Main Methods:
- Review of classical standardization concepts.
- Application of standardization through modeling, weighting, and matching.
- Use of logistic regression and other statistical models for causal inference.
- Example analysis using smoking data from the ARIC study.
Main Results:
- Standardization offers a solution to methodological shortcomings in typical regression analyses.
- Clinically interpretable risk differences and ratios can be estimated using standardization.
- Standard statistical software can re-express results in meaningful metrics.
Conclusions:
- Standardization is valuable for estimating risks, differences, and ratios for binary outcomes.
- Regression modeling combined with standardization enhances causal inference.
- This approach improves the transparency and clinical utility of risk assessment in health research.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Odds Ratio
Relative Risk
Regression Toward the Mean

